Health
Clarivate Reveals Stronger Outlook for Pulsed-field Ablation Market and Potential for Device to Revolutionize Treatment Paradigm
MedTech Insights report series analyzes the impact of recent breakthroughs in pulsed-field ablation, signaling its promising future in the electrophysiology mapping and ablation device market LONDON, Dec. 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people an...
2023-12-19 15:00
1545
Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports
* Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilitating multidisciplinary team collaboration and optimising care decisions * navify POC Operations attains excellent ratings from health professio...
2023-12-19 14:00
4142
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
ROCKVILLE, Md. and SUZHOU, China, Dec. 19, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology an...
2023-12-19 08:00
6692
Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer
MELBOURNE, Australia and INDIANAPOLIS, Dec. 19, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) tothe United States (U.S.) Food and Drug Administration (FDA) for its investigational pos...
2023-12-19 05:44
1674
EQT Private Equity to acquire Zeus, a global leader in advanced polymer components used in life-saving medical procedures
* EQT Private Equity to acquire Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies * Transaction highlights EQT's commitment to partnering with leading, purpose-driven companies that deliver inherently critical service...
2023-12-18 23:30
1594
Tsingke Congratulates iGEM 2023 SYSU-Software on Winning GOLD MEDAL for BioRocket Project
BEIJING and PARIS, Dec. 18, 2023 /PRNewswire/ -- The 2023 International Genetically Engineered Machine Competition (iGEM), the global synthetic biology competition, concluded onNovember 5, 2023. Over 7,000 students from high schools and universities, organized into more than 400 teams worldwide, ...
2023-12-18 22:13
1270
RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770
GERMANTOWN, Md and GUANGZHOU, China, Dec. 18, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announc...
2023-12-18 22:04
2397
Biorithm Secures $3.5 Million in Series A Funding to Advance Maternal Care Worldwide
New funds to fortify US market entry and growth strategy, as well as advance breakthrough research CAMBRIDGE, Mass., Dec. 18, 2023 /PRNewswire/ -- Biorithm, a global women's health medtech, has closed$3.5 million in Series A funding, co-led by Adaptive Capital Partners and SEEDS Capital. With a ...
2023-12-18 22:00
1495
GomSpace enters into Joint Venture with French company Ellipse Partners SAS
STOCKHOLM, Dec. 18, 2023 /PRNewswire/ -- GomSpace and Ellipse Projects SAS from France enters a Joint Venture with the purpose of acquiring a contract for monitoring of marine and fishing resources aroundIndonesia. A Tender of a potential value of 150 MEUR (1.6 BSEK), has been awarded to the Join...
2023-12-18 21:48
1499
RemeGen Announces Continued Inclusion of Telitacicept and Disitamab Vedotin in China National Reimbursement Drug List, Ensuring Continuous Accessibility of Innovative Drugs for More Patients
YANTAI, China, Dec. 18, 2023 /PRNewswire/ -- RemeGen Co. Ltd.
2023-12-18 20:56
1598
Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries
10+ Emerging Markets, Japan & ANZ Transition in Final Phase KUALA LUMPUR, Malaysia, Dec. 18, 2023 /PRNewswire/ -- Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully concluded the integration of th...
2023-12-18 20:44
2132
Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Highlights: * Significant improvement was assessed by both clinicians and caregivers across multiple efficacy measures * Improvements were consistently seen across clinically important aspects of Phelan-McDermid syndrome, including communication, behaviour, cognition/learning and socialis...
2023-12-18 19:00
1255
NUS researchers develop an innovative and flexible method to study immune cell capabilities
This simple and efficient method can directly identify and sort immune cells involved in cell-mediated cytotoxicity SINGAPORE, Dec. 17, 2023 /PRNewswire/ -- Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infection...
2023-12-18 14:47
1500
IDS Medical Systems Philippines, Inc.'s Corporate Excellence has been Acknowledged at the Asia Pacific Enterprise Awards 2023 Regional Edition
SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- In a dazzling celebration of regional excellence, the Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition took center stage to honor outstanding businesses and visionary leaders who have played a pivotal role in propelling their enterprises to new ...
2023-12-18 10:08
1692
Dr. Steve Mark Gan and His Company GAOC Group of Companies Claim Victory at the Asia Pacific Enterprise Awards 2023 Regional Edition
SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- The Asia Pacific Enterprise Awards (APEA) 2023 Regional Edition served as a magnificent tribute to exceptional businesses and forward-thinking leaders in the region. Following the Asia Economic Forum (AEF) 2023 inSingapore, which convened over 300 delegate...
2023-12-18 10:06
1811
GC Biopharma Announces US FDA Approval for ALYGLO™ (Immune Globulin Intravenous, Human-stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI)
YOGIN, South Korea, Dec. 17, 2023 /PRNewswire/ -- GC Biopharma Corp (006280.KS) today announces that the US Food and Drug Administration (FDA) has approved ALYGLO (immune globulin intravenous, human-stwk) 10% Liquid, formerly referred to as "GC5107," for the treatment of adult patients aged 17...
2023-12-18 09:49
1602
GeneQuantum and BioMap establish a strategic collaboration to jointly develop a series of next-generation ADC therapeutics
SUZHOU, China, Dec. 17, 2023 /PRNewswire/ -- Recently, GeneQuantum Healthcare (GQ), a global leader in ADC new drug development focused on innovative bioconjugation technologies, and BioMap, a global leader in life science AI Foundation protein-centric Large Language Models, announced that the...
2023-12-18 09:43
1432
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
ROCKVILLE, Md. and SUZHOU, China, Dec. 18, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-12-18 08:00
6354
Mediwave Unveils World's First Mixed Reality & AI-Powered Connected Ambulance
SINGAPORE, Dec. 18, 2023 /PRNewswire/ -- In a groundbreaking development, Mediwave, the digital healthcare arm of Wavenet, headquartered inSingapore, partners with 1990 Suwa Seriya,Sri Lanka's national pre-hospital emergency ambulance service, to elevate life-enhancing emergency care through Mixe...
2023-12-18 08:00
2066
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
SHANGHAI, Dec. 17, 2023 /PRNewswire/ -- YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's firstin vivo genome editing candidate being developed as a single dose, potentially curative therapy for hereditary transthyretin amyloidosis with cardio...
2023-12-17 23:15
1628
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 293 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
2024-11-12 09:00
5652
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
2024-11-11 21:00
5652
Sobot Introduces its All-in-One Solution at GITEX Global 2024
2024-11-12 11:00
5608